Literature DB >> 21684288

MicroRNA-9 is an activation-induced regulator of PDGFR-beta expression in cardiomyocytes.

Jianhu Zhang1, Vishnu Chintalgattu, Tiffany Shih, Di Ai, Ying Xia, Aarif Y Khakoo.   

Abstract

The platelet derived growth factor receptor (PDGFR) is an important target for novel anti-cancer therapeutics, but agents targeting PDGFR have been associated with cardiotoxicity. Cardiomyocyte PDGFR-β signaling in pressure-overloaded hearts induces compensatory angiogenesis via a paracrine-signaling cascade. Tight regulation of receptor tyrosine kinases in response to ligand stimulation is a critical part of any such cascade. The objective of the present study was to characterize the early and late regulation of PDGFR-β following ligand stimulation and define a potential role for microRNAs (miRNAs) predicted to interact with the 3'UTR of PDGFR-β in feedback regulation. Using two in-vitro model systems (U87 glioblastoma cells and neonatal cardiomyocytes), we observed that in response to stimulation with PDGF-BB, levels of PDGFR-β declined beginning at one hour, persisting for 48 h. PDGFR-β mRNA levels declined beginning at 6h after receptor activation. Early, but not late activation-induced receptor downregulation was proteasome dependent. Levels of miRNA-9 (miR-9) were significantly increased in U87 cells and cardiomyocytes beginning 6h after addition of ligand. In response to pressure overload, miR-9 levels were significantly reduced in the hearts of cardiac-specific PDGFR-β knockout mice. Luciferase reporter assays demonstrate that miR-9 directly interacts with its predicted seed in the 3'UTR of PDGFR-β. Increasing miR-9 levels reduces levels of PDGFR-β, resulting in a reduction in the paracrine angiogenic capacity of cardiomyocytes, consistent with the established function of cardiomyocyte PDGFR-β. Importantly, increase of anti-miR-9 in cardiomyocytes attenuates ligand-induced PDGFR-β downregulation. In conclusion, we have identified miR-9 as an activation-induced regulator of PDGFR-β expression in cardiomyocytes that is part of a negative feedback loop which serves to modulate PDGFR-β expression upon ligand-stimulation through direct interaction with the 3'UTR of PDFGR-β. This article is part of a Special Issue entitled 'Possible Editorial'.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21684288     DOI: 10.1016/j.yjmcc.2011.05.019

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  17 in total

1.  Suppression and epigenetic regulation of MiR-9 contributes to ethanol teratology: evidence from zebrafish and murine fetal neural stem cell models.

Authors:  Dana L Pappalardo-Carter; Sridevi Balaraman; Pratheesh Sathyan; Eric S Carter; Wei-Jung A Chen; Rajesh C Miranda
Journal:  Alcohol Clin Exp Res       Date:  2013-06-25       Impact factor: 3.455

2.  Myocardin: new therapeutic agent in vascular disease?

Authors:  Xiaochun Long; Joseph M Miano
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-10       Impact factor: 8.311

Review 3.  PDGF: the nuts and bolts of signalling toolbox.

Authors:  Ammad Ahmad Farooqi; Salman Waseem; Asma M Riaz; Bilal Ahmed Dilawar; Shahzeray Mukhtar; Sehrish Minhaj; Makhdoom Saad Waseem; Suneel Daniel; Beenish Ali Malik; Ali Nawaz; Shahzad Bhatti
Journal:  Tumour Biol       Date:  2011-07-19

4.  MicroRNA-9 inhibits hyperglycemia-induced pyroptosis in human ventricular cardiomyocytes by targeting ELAVL1.

Authors:  Prince Jeyabal; Rajarajan A Thandavarayan; Darukeshwara Joladarashi; Sahana Suresh Babu; Shashirekha Krishnamurthy; Arvind Bhimaraj; Keith A Youker; Raj Kishore; Prasanna Krishnamurthy
Journal:  Biochem Biophys Res Commun       Date:  2016-02-17       Impact factor: 3.575

5.  MiR-9-5p Down-Regulates PiT2, but not PiT1 in Human Embryonic Kidney 293 Cells.

Authors:  D P Bezerra; M Keasey; J R M Oliveira
Journal:  J Mol Neurosci       Date:  2017-03-16       Impact factor: 3.444

6.  miR-30b-5p acts as a tumor suppressor microRNA in esophageal squamous cell carcinoma.

Authors:  Jianfeng Xu; Haiyan Lv; Bo Zhang; Feng Xu; Hongyu Zhu; Baofu Chen; Chengchu Zhu; Jianfei Shen
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

7.  The clinical and prognostic value of miR-9 gene expression in Tunisian patients with bladder cancer.

Authors:  Lucia Cicchillitti; Rahma Said; Nouha Setti Boubaker; Aymone Gurtner; Haroun Ayed; Ahlem Blel; Omar Karray; Mohamed Ali Essid; Maroua Gharbi; Abderrazek Bouzouita; Soumaya Rammeh Rommeni; Mohamed Chebil; Giulia Piaggio; Slah Ouerhani
Journal:  Mol Biol Rep       Date:  2019-06-18       Impact factor: 2.316

8.  Regulation of microRNA expression and function by nuclear receptor signaling.

Authors:  Zhihong Yang; Li Wang
Journal:  Cell Biosci       Date:  2011-09-21       Impact factor: 7.133

9.  microRNA-378 promotes mesenchymal stem cell survival and vascularization under hypoxic-ischemic conditions in vitro.

Authors:  Yue Xing; Jingying Hou; Tianzhu Guo; Shaoxin Zheng; Changqing Zhou; Hui Huang; Yuyang Chen; Kan Sun; Tingting Zhong; Jingfeng Wang; Honghao Li; Tong Wang
Journal:  Stem Cell Res Ther       Date:  2014-11-23       Impact factor: 6.832

Review 10.  Platelet-derived growth factor receptor/platelet-derived growth factor (PDGFR/PDGF) system is a prognostic and treatment response biomarker with multifarious therapeutic targets in cancers.

Authors:  Kwaku Appiah-Kubi; Ying Wang; Hai Qian; Min Wu; Xiaoyuan Yao; Yan Wu; Yongchang Chen
Journal:  Tumour Biol       Date:  2016-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.